tiprankstipranks
Trending News
More News >
Relmada Therapeutics’ Earnings Call: Promising Data Amid Financial Concerns
PremiumCompany AnnouncementsRelmada Therapeutics’ Earnings Call: Promising Data Amid Financial Concerns
1M ago
VA secretary wants to find answers on psychedelics therapies, Politico says
Premium
The Fly
VA secretary wants to find answers on psychedelics therapies, Politico says
1M ago
Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
Premium
The Fly
Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
1M ago
Relmada Therapeutics: Hold Rating Amid Uncertainty and Strategic Shifts
PremiumRatingsRelmada Therapeutics: Hold Rating Amid Uncertainty and Strategic Shifts
3M ago
Relmada Therapeutics: Strategic Acquisitions and Pipeline Progress
Premium
Company Announcements
Relmada Therapeutics: Strategic Acquisitions and Pipeline Progress
3M ago
Relmada Therapeutics Reports 2024 Financial Results and Strategic Progress
Premium
Company Announcements
Relmada Therapeutics Reports 2024 Financial Results and Strategic Progress
3M ago
Psychedelic: Exclusive talk with biotech company Enveric Biosciences
PremiumThe FlyPsychedelic: Exclusive talk with biotech company Enveric Biosciences
4M ago
Psychedelic: Relmada acquires neurosteroid from Asarina
Premium
The Fly
Psychedelic: Relmada acquires neurosteroid from Asarina
5M ago
Relmada Therapeutics acquires Sepranolone from Asarina Pharma
Premium
The Fly
Relmada Therapeutics acquires Sepranolone from Asarina Pharma
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100